APA (7th ed.) Citation

SJ, Y., AK, S., T, D., T, T., Y, H., F, B., . . . JH, B. (2022). Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models. Science translational medicine, 14(665), eabn1716. https://doi.org/10.1126/scitranslmed.abn1716

Chicago Style (17th ed.) Citation

SJ, Yang, et al. "Pancreatic Islet-specific Engineered Tregs Exhibit Robust Antigen-specific and Bystander Immune Suppression in Type 1 Diabetes Models." Science Translational Medicine 14, no. 665 (2022): eabn1716. https://doi.org/10.1126/scitranslmed.abn1716.

MLA (9th ed.) Citation

SJ, Yang, et al. "Pancreatic Islet-specific Engineered Tregs Exhibit Robust Antigen-specific and Bystander Immune Suppression in Type 1 Diabetes Models." Science Translational Medicine, vol. 14, no. 665, 2022, p. eabn1716, https://doi.org/10.1126/scitranslmed.abn1716.